Our results showed that SP600125 pre-treatment before MSM treatment caused a decrease in the number of early apoptotic (PE+/7-AAD−) HCT-116 p53 +/+ and HCT-116 p53 −/− colon cancer cells. Here, TP53 is linked to colonic neoplasm.